• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性脑缺血中的炎症和神经免疫调节变化

Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.

作者信息

Brea David, Sobrino Tomás, Ramos-Cabrer Pedro, Castillo José

机构信息

Clinical Neuroscience Research Laboratory, Department of Neurology, Hospital Clínico Universitario de Santiago de Compostela, University of Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Cerebrovasc Dis. 2009;27 Suppl 1:48-64. doi: 10.1159/000200441. Epub 2009 Apr 3.

DOI:10.1159/000200441
PMID:19342833
Abstract

Neuronal death produced by cerebral ischemia activates innate immunity by Toll-like receptors and triggers inflammatory response. This response is necessary to remove cell debris and to start regenerative process. However, inflammatory response could exacerbate cerebral damage and it is involved in secondary brain damage. Therefore, organisms have developed different mechanisms to regulate inflammatory response. An accurate balance between inflammation and anti-inflammation is necessary to assure the removal of cell debris and to avoid secondary cell damage. New therapeutic targets could be designed to obtain a correct modulation of the immune system and to reduce cerebral brain damage after cerebral ischemia. In this paper, we review the function of the immune system in cerebral ischemia, particularly inflammation and immunomodulation.

摘要

脑缺血导致的神经元死亡通过Toll样受体激活先天免疫并引发炎症反应。这种反应对于清除细胞碎片和启动再生过程是必要的。然而,炎症反应可能会加剧脑损伤,并且它参与继发性脑损伤。因此,生物体已经发展出不同的机制来调节炎症反应。炎症与抗炎之间的精确平衡对于确保细胞碎片的清除和避免继发性细胞损伤是必要的。可以设计新的治疗靶点来实现对免疫系统的正确调节,并减少脑缺血后的脑损伤。在本文中,我们综述了免疫系统在脑缺血中的功能,特别是炎症和免疫调节。

相似文献

1
Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.急性脑缺血中的炎症和神经免疫调节变化
Cerebrovasc Dis. 2009;27 Suppl 1:48-64. doi: 10.1159/000200441. Epub 2009 Apr 3.
2
[Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation].[缺血过程中的炎症反应:黏附分子与免疫调节]
Rev Neurol. 2010 Jul 1;51(1):30-40.
3
Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.Toll样受体及细胞因子信号传导的抑制——缺血耐受中的一个统一主题。
J Cereb Blood Flow Metab. 2004 Nov;24(11):1288-304. doi: 10.1097/01.WCB.0000145666.68576.71.
4
Inflammation in ischaemic brain injury: current advances and future perspectives.缺血性脑损伤中的炎症:当前进展与未来展望。
Clin Exp Pharmacol Physiol. 2010 Feb;37(2):253-8. doi: 10.1111/j.1440-1681.2009.05279.x. Epub 2009 Aug 28.
5
Inflammation, plasticity and real-time imaging after cerebral ischemia.脑缺血后的炎症、可塑性与实时成像
Acta Neuropathol. 2009 May;117(5):497-509. doi: 10.1007/s00401-009-0496-1. Epub 2009 Feb 19.
6
An immunological approach to cerebral ischemia (I). Immune cells and adhesion molecules.脑缺血的免疫学研究方法(I)。免疫细胞与黏附分子。
Rom J Intern Med. 2008;46(1):3-8.
7
[Regulatory mechanisms in focal cerebral ischemia. New possibilities in neuroprotective therapy].
Ideggyogy Sz. 2002 Mar 20;55(3-4):73-85.
8
Innate immunity, local inflammation, and degenerative disease.固有免疫、局部炎症与退行性疾病。
Sci Aging Knowledge Environ. 2002 Jul 24;2002(29):re3. doi: 10.1126/sageke.2002.29.re3.
9
Cerebral ischemia, mechanisms and therapeutic approaches--current status.脑缺血:机制与治疗方法——现状
Curr Opin Investig Drugs. 2006 Jul;7(7):595-9.
10
Toll-like receptors in cerebral ischemic inflammatory injury.脑缺血性炎症损伤中的 Toll 样受体。
J Neuroinflammation. 2011 Oct 8;8:134. doi: 10.1186/1742-2094-8-134.

引用本文的文献

1
LncRNA 220: A Novel Long Non-Coding RNA Regulates Autophagy and Apoptosis in Kupffer Cells via the miR-5101/PI3K/AKT/mTOR Axis in LPS-Induced Endotoxemic Liver Injury in Mice.LncRNA 220:通过 miR-5101/PI3K/AKT/mTOR 轴调控脂多糖诱导的内毒素血症小鼠枯否细胞自噬和凋亡的新型长非编码 RNA
Int J Mol Sci. 2023 Jul 7;24(13):11210. doi: 10.3390/ijms241311210.
2
Therapeutic effects of polydeoxyribonucleotide in an in vitro neuronal model of ischemia/reperfusion injury.聚脱氧核苷酸在体外脑缺血/再灌注损伤神经元模型中的治疗作用。
Sci Rep. 2023 Apr 12;13(1):6004. doi: 10.1038/s41598-023-32744-9.
3
Association of genetic variants and mRNA expression with the risks of ischemic stroke and long-term death after stroke.
基因变异和mRNA表达与缺血性中风风险及中风后长期死亡的关联。
Front Aging Neurosci. 2022 Sep 23;14:1006473. doi: 10.3389/fnagi.2022.1006473. eCollection 2022.
4
Ellagic Acid and Its Anti-Aging Effects on Central Nervous System.鞣花酸及其对中枢神经系统的抗衰老作用。
Int J Mol Sci. 2022 Sep 19;23(18):10937. doi: 10.3390/ijms231810937.
5
Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier.缺血性脑卒中治疗范式转变的必要性:血脑屏障。
Int J Mol Sci. 2022 Aug 22;23(16):9486. doi: 10.3390/ijms23169486.
6
Stroke-derived neutrophils demonstrate higher formation potential and impaired resolution of CD66b + driven neutrophil extracellular traps.脑卒中来源的中性粒细胞表现出更高的形成潜能和受损的 CD66b+驱动的中性粒细胞胞外诱捕网的解决能力。
BMC Neurol. 2022 May 20;22(1):186. doi: 10.1186/s12883-022-02707-0.
7
Efficacy and Safety of (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design.(血栓通)治疗急性缺血性脑卒中患者的疗效与安全性(EXPECT)试验:原理与设计
Front Pharmacol. 2021 Apr 22;12:648921. doi: 10.3389/fphar.2021.648921. eCollection 2021.
8
Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway.腺嘌呤 A2A 受体激动剂聚脱氧核糖核苷酸通过 MAPK 通路抑制脑缺血诱导的炎症改善短期记忆障碍。
PLoS One. 2021 Mar 18;16(3):e0248689. doi: 10.1371/journal.pone.0248689. eCollection 2021.
9
Thinking outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke.跳出缺血框框思考:多发性硬化症药物在缺血性卒中治疗中的应用进展
J Clin Med. 2021 Feb 7;10(4):630. doi: 10.3390/jcm10040630.
10
A cross-sectional study to assess the association between major depression and inflammatory markers in patients with acute ischemic stroke.一项评估急性缺血性中风患者中重度抑郁症与炎症标志物之间关联的横断面研究。
Indian J Psychiatry. 2019 May-Jun;61(3):283-289. doi: 10.4103/psychiatry.IndianJPsychiatry_175_18.